Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Pediatr Blood Cancer. 2018 Nov 4;66(3):e27542. doi: 10.1002/pbc.27542

FIGURE 5.

FIGURE 5

Survival and relapse risk for patients age 15–17.99 years stratified by ATO consolidation treatment. Kaplan-Meier plots for overall survival (a) and event free survival (b) are not significantly different, but relapse risk (c) was lower among patients who received ATO. In figure 5c, the relapse risk lines for both “ATO, relapse” and “No ATO, death without relapse” are overlapping on the 0% probability line.